Zvika Rubinstein

Protea Vaccine Technologies Ltd has developed a proprietary identification and prioritization platform for the discovery of conserved protein antigens. Using this platform, Protea has defined a group of conserved protein antigens that provide protective immunity against lethal challenge by S. pneumoniae in mouse challenge models. Protea is based in Israel, having been established as Portfolio Company at Meytav Technological Incubator, Tel-Hay Israel.

Quinova Rx Ltd. develops cannabinoid quinone scaffold for antineoplastic therapy. The company was founded by Natalya Kogan in May 2007 and is headquartered in Kiryat Shmona, Israel.

ReproMed Ltd. develops proprietary sperm preparation devices for infertility treatments. Its products include Gradiator and OviTherm. The company was founded by Eran Cohen and Daniel Katz in January 2004 and is headquartered in Kiryat Shmona, Israel.

ReLeaf Medical Ltd. develops medical devices to treat calcification related diseases. The company was founded by Moshe Y. Flugelman and Yael Nir in September 2006 and is headquartered in Kiryat Shmona, Israel.

SimeTRA Pharm Ltd. develops drugs and therapies for cancer. It focuses on treating hematopoietic cancers. The company was founded by Sarit Larisch in 2004 and is headquartered in Kiryat Shmona, Israel.

Thera-P Ltd. develops novel reversible pegylation technology. It is based on a technology platform of reversible pegylation of proteins, peptides, and small molecules. The company was founded in August 2007 and is headquartered in Kiryat Shmona, Israel

UC-Care Ltd. Operates as a medical device company. It is developing a patented diagnostic and treatment system aimed to improve diagnostic and treatment procedures of prostate diseases. The firm’s products include Navigo, Navigo Viewer and SmartBX. The company was founded by Roni Zvuloni and Shaike Schatzberger in July 2004 and is headquartered in Yokneam, Israel.

Agamit Medical Ltd. develops devices and solutions for patients suffering from Mitral regurgitation. The company was founded in February 2008 by Gad Keren and is headquartered in Kiryat Shmona, Israel.

Lartim Medical Ltd. operates as a development stage company. The company was founded by Boris Orlov in 2008 and is headquartered in Kiryat Shmona, Israel.

CyToD develops therapeutic approach to treat such chronic asthma and rheumatoid arthritis. It focuses on the pathways that restrict homing of specific subsets of immune cells to their activation sites in the lymph nodes and sites of inflammation and thereby fine tune the immune response. The company was founded by Idit Shachar and Liat Flaishon in 2008 and is headquartered in Tel Hai, Israel.